COVID-19 Vaccines and Administrations

Blue Cross Blue Shield of North Dakota (BCBSND) is committed to keeping providers informed of the billing and coding guidelines for the COVID-19 vaccines and administration. Visit our website under our Provider COVID-19 webpage for the most current COVID-19 vaccine and administration related information.

The American Medical Association (AMA) released the following codes for the COVID-19 vaccine and vaccine administration.
 
Vaccine

  • 91300 – Use in Conjunction with 0001A or 0002A
  • 91301 – Use in Conjunction with 0011A or 0012A
  • 91302 – Use in Conjunction with 0021A or 0022A 

Vaccine Administration

  • 0001A – First Vaccine Dose Administration use in conjunction with 91300
  • 0002A – Second Vaccine Dose Administration use in conjunction with 91300
  • 0011A – First Vaccine Dose Administration use in conjunction with 91301
  • 0012A – Second Vaccine Dose Administration use in conjunction with 91301
  • 0021A – First Vaccine Dose Administration use in conjunction with 91302
  • 0022A – Second Vaccine Dose Administration use in conjunction with 91302 

Providers should refer to the Modifier SL – State Supplied Vaccinations reimbursement policy for billing guidelines related to state-issued COVID-19 vaccines.
 
Note:  Services Related to COVID-19 Vaccines and Vaccine Administration
Providers rendering a significantly separate and identifiable office visit related to a COVID-19 vaccination received on the same date as the office visit must append modifier 32, CR, or CS to the office visit on professional and outpatient facility claims in conjunction to modifier 25. Providers should not report an office visit code if the only service provided is the COVID-19 vaccine and administration.
 
For correction of claims please refer to our COVID-19 related claim corrections guidelines.